Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 83 publications
Benefits of eptinezumab on patient-reported disease burden and health-related quality of life in adults with chronic migraine and medication-overuse headache: Results from the placebo-controlled RESOLUTION trial.
Journal: Cephalalgia : an international journal of headache
Published: May 16, 2026
Efficacy and safety of eptinezumab in adults with chronic migraine and medication-overuse headache who also received patient education: 24-week results of the randomized RESOLUTION trial.
Journal: The journal of headache and pain
Published: April 24, 2026
Safety, tolerability, and efficacy of atogepant added to onabotulinumtoxinA for the preventive treatment of chronic migraine: A phase 3, multicenter, 24-week, open-label study.
Journal: Cephalalgia : an international journal of headache
Published: April 07, 2026
Eptinezumab With Patient Education for Chronic Migraine and Medication-Overuse Headache: The Randomized, Placebo-Controlled RESOLUTION Trial.
Journal: Neurology
Published: March 26, 2026
Long-Term Reductions in Headache Frequency, Severity, and Disability with Eptinezumab in Adults with Chronic Migraine: Results from the PREVAIL Trial.
Journal: Pain and therapy
Published: December 16, 2025
OnabotulinumtoxinA for the preventive treatment of episodic migraine: Results from the phase 3, multicenter randomized, double-blind, placebo-controlled phase of the PRECLUDE trial.
Journal: Cephalalgia : an international journal of headache
Published: October 15, 2025
Real-World Retrospective Safety Analysis of OnabotulinumtoxinA for the Treatment of Patients with Chronic Migraine and Concomitant Therapeutic Indications.
Journal: Pain and therapy
Published: September 18, 2025
When should the effectiveness of a botulinum toxin A for chronic migraine be assessed in the face of newest International Headache Society recommendations?
Journal: Cephalalgia : an international journal of headache
Published: July 30, 2025
Correction to: Real‑World Evidence of the Safety and Effectiveness of Atogepant Added to OnabotulinumtoxinA for the Preventive Treatment of Chronic Migraine: A Retrospective Chart Review.
Journal: Pain and therapy
Published: December 24, 2024
Cerebral Artery Vasoconstriction After Galcanezumab Loading Dose for Migraine Prevention: A Case Report.
Journal: Pain and therapy
Published: September 04, 2024
What Is Combination Treatment in Migraine? Moving Toward a Uniform Definition of a Familiar Principle.
Journal: Neurology and therapy
Published: August 19, 2024
Last Updated: 09/26/2026